1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Evolution of P-wave indices during long-term follow-up as markers of atrial substrate progression in arrhythmogenic right ventricular cardiomyopathy
Baturova, Maria A. LU ; Svensson, Anneli ; Aneq, Meriam Åström ; Svendsen, Jesper H. ; Risum, Niels ; Sherina, Valeriia ; Bundgaard, Henning ; Meurling, Carl LU ; Lundin, Catarina LU and Carlson, Jonas LU
, et al.
(2021)
In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
23(1).
p.29-37
Mark
- Reply to : TFC ECG in arrhythmogenic cardiomyopathy: Inadequate mixture of criteria?
- 2020
-
External validation of the HANDOC score–high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis
Sunnerhagen, Torgny LU
; Højgaard Andersen, Malene
; Bruun, Niels Eske
; Bundgaard, Henning
; Iversen, Kasper Karmark
and Rasmussen, Magnus
LU
(2020)
In Infectious Diseases
52(1).
p.54-57
Mark
- Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry)
- Absence of ECG Task Force Criteria does not rule out structural changes in genotype positive ARVC patients
- Atrial fibrillation as a clinical characteristic of arrhythmogenic right ventricular cardiomyopathy : Experience from the Nordic ARVC Registry
- Pregnancies, ventricular arrhythmias, and substrate progression in women with arrhythmogenic right ventricular cardiomyopathy in the Nordic ARVC Registry
- Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
- 2019
- In-hospital metabolite changes in infective endocarditis—a longitudinal 1H NMR-based study
-
Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Platonov, Pyotr G. LU ; Haugaa, Kristina H. ; Bundgaard, Henning ; Svensson, Anneli ; Gilljam, Thomas ; Hansen, Jim ; Madsen, Trine ; Holst, Anders Gaarsdal ; Carlson, Jonas LU
and Lie, Øyvind H.
, et al.
(2019)
In American Journal of Cardiology
123(7).
p.1156-1162
Mark